Stockreport

Virios Therapeutics Announces Second Quarter 2024 Financial Results

Virios Therapeutics, Inc.  (VIRI) 
PDF - Bateman Horne Center completed enrollment in its groundbreaking investigator-initiated Long-COVID phase 2a study featuring valacyclovir and celecoxib (IMC-2) - - To [Read more]